Blog Detail
International Stem Cell Blog
http://intlstemcell.blogspot.com
International Stem Cell is a biotechnology company currently focused on developing therapeutic and research products through the use of human stem cells. In the area of therapeutic product development, ISCO's objective is to create an unlimited source of human cells for use in the treatment of several diseases, including diabetes, liver disease and retinal disease through cell transplant therapy.
Recent Posts
International Stem Cell Corporation Announces Launch Strategy for Skin Care Product Line
Lifeline Skin Care, Inc, a wholly owned subsidiary of International Stem Cell Corporation (OTCBB:ISCO), www.internationalstemcell.com, announced today that it has retained the services of a highly exp...
International Stem Cell Corporation Collaborates with Scripps Research Institute\'s Center for Regenerative Medicine to Study Parthenogenetic Stem...
International Stem Cell Corporation Announces Collaboration with Scripps Research Institute's Center for Regenerative Medicine to Study Parthenogenetic Stem CellsInternational Stem Cell Corporation (OTCBB: ISCO), www.internationalstemcell.com...
International Stem Cell Corporation Announces Strategic Enhancement of its Management Team
International Stem Cell Corporation (OTCBB:ISCO), www.internationalstemcell.com announced today that it had made important strategic changes in its management team to leverage its growing opportunities in the therapeutic ...
Genetic Engineering & Biotechnology News: "Third Option for Stem Cell Research Emerges - Parthenogenesis Could Sidestep Some of the Moral"...
International Stem Cell Corporation CEO - Kenneth AldrichGenetic Engineering & Biotechnology News: Third Option for Stem Cell Research Emerges - Parthenogenesis Could Sidestep Some of the Moral and Immune Rejection IssuesRemember this term: Parth...
International Stem Cell Corporation CEO Kenneth Aldrich Speaks at Stem Cells USA & Regenerative Medicine Congress
/To display this email in a browser, please click here conference details Conference: Day 1 Nov 17, 8:30am - 5:30pm Day 2 Nov 18, 8:30am - 5:30pm Pre-conference workshop:Nov 16, 9am - 4:30pm› Register now and ...
International Stem Cell Corporation and Reproductive Medicine Associates of New York Announce Breakthrough in Creating an Abundant and Ethical New ...
International Stem Cell Corporation and Reproductive Medicine Associates of New York Announce Breakthrough in Creating an Abundant and Ethical New Source of Human Pluripotent Stem Cells Oceanside, Calif., October 27, 2009 — International Stem ...
